The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHikma Pharmaceuticals Share News (HIK)

Share Price Information for Hikma Pharmaceuticals (HIK)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,930.00
Bid: 1,920.00
Ask: 1,921.00
Change: 17.00 (0.89%)
Spread: 1.00 (0.052%)
Open: 1,921.00
High: 1,930.00
Low: 1,901.00
Prev. Close: 1,913.00
HIK Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Wednesday broker round-up UPDATE

Wed, 17th Apr 2013 07:20

African Barrick Gold: Deutsche Bank cuts target price from 230p to 173p, while its hold recommendation is reiterated.Ashmore Group: Morgan Stanley raises target price from 395p to 444p and maintains an equal-weight rating.Ashtead Group: Jefferies increases target price from 615p to 690o and reiterates a buy recommendation.Aquarius Platinum: Investec starts with a target price of 45p and a hold recommendation.British American Tabacco: Nomura lowers target price from 4087p to 4012p, while its buy recommendation remains unchanged.Cello Group: Sanlam Securities initiates with a target price of 75p and a buy recommendation.Derwent London: Investec raises target price from 2275p to 2360p and maintains an add rating.Escher Group Holdings: Panmure Gordon takes target price from 410p to 456p and reiterates a buy recommendation.Falkland Islands Hodlings: WH Ireland cuts target price from 480p to 448p retaining a buy recommendation.Fresnillo: Deutsche Bank takes tatget price from 1260p to 1040p and still recommends selling.Fusion IP: HB Markets initiates with a speculative buy.Hargreaves Lansdown: Jefferies increases target price from 1000p to 1150p, while maintaining a buy recommendation.Hays: HSBC Holdings ups target price from 80p to 106p and leaves its neutral rating unaltered.Hikma Pharmaceuticals: Jefferies reduces target price from 1150p to 1040p keeping a buy recommendation. Panmure Gordon cuts target price from 1100p to 1000p, while its buy recommendation remains unchanged.Imperial Tabacco: Nomura cuts target price from 2443p to 2386p and reiterates a reduce rating.Interbulk Group: Westhouse Securities shifts target price from 11p to 10p and keeps a buy recommendation.InterContinental Hotels Group: Barclays downgrades to equal-weight with a target price of 2085p.JD Sports Fashion: Investec increases target price from 830p to 860p staying with its buy recommendation.Legal & General Group: Investec raises target price from 153p to 193p keeping a hold recommendation.Man Group: Canaccord Genuity raises target price to 120p and upgrades from hold to buy.Michael Page: Jefferies cuts target price from 520p to 500p and retains a buy recommendation. JP Morgan reduces target price from 389p to 370p maintaining a neutral rating. Citigroup lowers target price from 440p to 400p, while leaving its neutral rating unchanged. Credit Suisse moves target price from 400p to 360p and stays with an underperform rating. HSBC Holdings takes target price from 450p to 414p and downgrades to neutral.Moneysupermarket.com: Westhouse Securities moves target price from 195p to 210p and upgrades from neutral to add.Randgold Resources: Deutsche Bank cuts target price from 6030p to 5500p, while maintaining a buy recommendation.Rio Tinto: Deutsche Bank reduces target price from 4521p to 4489p keeping a buy recommendation.Sepura: Investec shifts target price from113p to 115p and leaves its buy recommendation unchanged.Smiths News: N+1 Singer moves target price from 164p to 185p, but downgrades to hold.Speedy Hire: Panmure Gordon shifts target price from 56p to 60p maintaining a buy recommendation.Vodafone Group: Deutsche Bank shifts target price from 173p to 180p and maintains a hold recommendation. HSBC Holdings ups target price from 205p to 230p reiterating an overweight rating.
More News
1 Mar 2023 09:52

LONDON BROKER RATINGS: Canaccord says sell Future; Investec likes RWS

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
27 Feb 2023 09:38

Berenberg raises target price on Hikma Pharmaceuticals

(Sharecast News) - Analysts at Berenberg raised their target price on drugmaker Hikma Pharmaceuticals from 1,440.0p to 1,740.0p on Monday on the back of the group's recent trading update.

Read more
27 Feb 2023 09:26

LONDON BROKER RATINGS: Citi cuts Quilter to 'sell'; Goldman likes GSK

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
24 Feb 2023 09:37

LONDON BROKER RATINGS: SocGen cuts Burberry; BofA cuts WH Smith

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning and Thursday:

Read more
23 Feb 2023 09:54

Hikma Pharmaceuticals profit halves in 2022 on Generics impairment

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday reported a dip in annual revenue for 2022, as profit tumbled due to high inflation and adjustments regarding expectations for its Generics business.

Read more
23 Feb 2023 09:02

LONDON MARKET OPEN: Mixed open in London; Rolls-Royce up, Mondi down

(Alliance News) - Stock prices in London opened mixed on Thursday, with large-cap indices underperforming amid mixed corporate earnings.

Read more
23 Feb 2023 07:59

Competition in generics sees Hikma Pharmaceuticals's profits decline by a tenth

(Sharecast News) - Hikma Pharmaceuticals posted lower full-year profits as stiff competition in generics saw its top line growth flatten out.

Read more
23 Feb 2023 07:56

LONDON BRIEFING: WPP profit jumps in 2022; guides for further growth

(Alliance News) - Stocks in London were called to open slightly higher on Thursday, as investors were unfazed by a fairly uneventful set of policy meeting minutes from the US central bank.

Read more
22 Feb 2023 21:50

Hikma accuses Amarin of suppressing generic versions of heart pill

Hikma claims Amarin used exclusive agreements with suppliers to frustrate generic rivals

*

Read more
16 Feb 2023 15:49

UK earnings, trading statements calendar - next 7 days

Friday 17 February 
Allianz Technology Trust PLCFull Year Results
Kingspan Group PLCFull Year Results
NatWest Group PLCFull Year Results
Pod Point Group Holdings PLCFull Year Results
Segro PLCFull Year Results
Monday 20 February 
Bank of Cyprus Holdings PLCFull Year Results
Georgia Capital PLCFull Year Results
Goldplat PLCFull Year Results (TBC)
LungLife AI IncFull Year Results
Tristel PLCHalf Year Results
Wilmington PLCHalf Year Results
Tuesday 21 February 
Antofagasta PLCFull Year Results
BHP Group LtdHalf Year Results
Blancco Technology Group PLCHalf Year Results
Finsbury Food Group PLCHalf Year Results
HSBC Holdings PLCFull Year Results
InterContinental Hotels Group PLCFull Year Results
Safestore Holdings PLCTrading Statement
Smith & Nephew PLCFull Year Results
Springfield Properties PLCHalf Year Results
Sylvania Platinum LtdHalf Year Results
Trifast PLCTrading Statement
Wednesday 22 February 
Avingtrans PLCHalf Year Results
City of London Investment Group PLCHalf Year Results
Conduit Holdings LtdFull Year Results
Liberty Global PLCFull Year Results
Lloyds Banking Group PLCFull Year Results
Primary Health Properties PLCFull Year Results
Renewables Infrastructure Group LtdFull Year Results
Rio Tinto PLCFull Year Results
Synectics PLCFull Year Results
TBC Bank Group PLCFull Year Results
Transense Technologies PLCHalf Year Results
Thursday 23 February 
Anglo American PLCFull Year Results
Arbuthnot Banking Group PLCTrading Statement
BAE Systems PLCFull Year Results
Bluefield Solar Income Fund LtdHalf Year Results
Drax Group PLCFull Year Results
Driver Group PLCFull Year Results
Genus PLCHalf Year Results
Hays PLCHalf Year Results
Hikma Pharmaceuticals PLCFull Year Results
Howden Joinery Group PLCFull Year Results
Macfarlane Group PLCFull Year Results
Made Tech Group PLCHalf Year Results
Mondi PLCFull Year Results
Morgan Sindall Group PLCFull Year Results
Pantheon International PLCHalf Year Results
Rolls-Royce Holdings PLCFull Year Results
Serco Group PLCFull Year Results
Spectris PLCFull Year Results
Versarien PLCFull Year Results
WPP PLCFull Year Results
  
Copyright 2023 Alliance News Ltd. All Rights Reserved. 

Read more
25 Jan 2023 09:33

LONDON BROKER RATINGS: Goldman likes UK banks; HSBC cuts Dr Martens

(Alliance News) - The following London-listed shares received analyst recommendations Wednesday morning:

Read more
18 Jan 2023 15:07

Director dealings: Hikma Pharmaceuticals director snaps up shares

(Sharecast News) - Hikma Pharmaceuticals revealed on Wednesday that non-executive director Deneen Vojta had acquired 1,000 ordinary shares in the FTSE 250-listed drugmaker.

Read more
12 Jan 2023 17:55

Arecor transfers AT307 drug to Hikma for development, regains AT282

(Alliance News) - Arecor Therapeutics PLC on Thursday said it transferred development activities for the ready-to-use injectable medicine AT307 to Hikma Pharmaceuticals PLC, and regained rights on AT282 after a product portfolio review.

Read more
3 Jan 2023 17:31

FTSE 100 ends first trading day of 2023 on upbeat note

FTSE 100 up 1.4%, FTSE 250 adds 1.5%

*

Read more
3 Jan 2023 09:25

Hikma launches version of Xyrem medicine in US for treating narcolepsy

(Alliance News) - Hikma Pharmaceuticals PLC on Tuesday said it launched an authorised generic version of the Xyrem sodium oxybate prescription medicine in the US for treating narcolepsy.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.